Roik Marek, Wretowski Dominik, Łabyk Andrzej, Kostrubiec Maciej, Irzyk Katarzyna, Dzikowska-Diduch Olga, Lichodziejewska Barbara, Ciurzyński Michał, Kurnicka Katarzyna, Gołębiowski Marek, Pruszczyk Piotr
Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland.
Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland.
Int J Cardiol. 2016 Jan 15;203:228-35. doi: 10.1016/j.ijcard.2015.10.116. Epub 2015 Oct 23.
BACKGROUND/OBJECTIVES: Balloon pulmonary angioplasty (BPA) is an emerging therapeutic method in CTEPH. We aimed to prove the safety and efficacy of refined BPA driven by combined assessment of intra-arterial anatomy (IVUS/OCT) and physiology (pulmonary pressure ratio, PPR) in non-operable distal CTEPH.
11 pts (mean age 76, 59–84, 7 males) were enrolled in the BPA program according to the following inclusion criteria: 1. Non-operable CTEPH; 2. RHC with mPAP > 30 mm Hg; 3. At least one segmental perfusion defect at lung scintigraphy; 4. WHO class > II. Overall, 9 pts underwent 27 BPA sessions (mean 3 sessions per patient, range 1–5), 50 pulmonary arteries were dilated (mean 6 vessels per patient, range 3–9; 2.03 dilated arteries per session). All the angioplasties were performed according to an algorithm, which incorporated anatomical and functional assessment of targeted lesions.
We performed BPA of 32 web lesions, 5 ring-like stenosis and 13 complete obstructions. BPA resulted in clinical and hemodynamic improvement. WHO class improved from pre-BPA to post-BPA (p = 0.018), and 6 MWD increased from 304 m to 384 m (p = 0.03), NT-proBNP dropped from 1248 pg/ml to 730 pg/ml (p < 0.001). Mean PAP and PVR decreased (p = 0.01), while CO and CI increased (p = 0.01). All dilated arteries were patent at angiographic reassessment. No significant complications occurred and all treated patients are still alive. Insignificant transient reperfusion pulmonary oedema occurred in only 2 patients, who responded well to supplemental oxygen.
Refined BPA with assessment of intrapulmonary physiology using a pressure wire and precise evaluation of anatomy with IVUS and OCT provides hemodynamic and functional improvement, with minimal complications in distal non-operable CTEPH. This observation requires further validation in a large prospective study.
背景/目的:球囊肺动脉血管成形术(BPA)是慢性血栓栓塞性肺动脉高压(CTEPH)中一种新兴的治疗方法。我们旨在证明在无法手术的远端CTEPH中,通过联合评估动脉内解剖结构(血管内超声/光学相干断层扫描,IVUS/OCT)和生理学指标(肺压力比值,PPR)来指导的改良BPA的安全性和有效性。
根据以下纳入标准,11例患者(平均年龄76岁,59 - 84岁,7例男性)纳入BPA治疗项目:1. 无法手术的CTEPH;2. 右心导管检查显示平均肺动脉压(mPAP)> 30 mmHg;3. 肺闪烁显像至少有一个节段性灌注缺损;4. 世界卫生组织(WHO)心功能分级> II级。总体而言,9例患者接受了27次BPA治疗(平均每位患者3次,范围1 - 5次),扩张了50支肺动脉(平均每位患者6支,范围3 - 9支;每次治疗平均扩张2.03支动脉)。所有血管成形术均按照一种算法进行,该算法纳入了对目标病变的解剖和功能评估。
我们对32处网状病变、5处环状狭窄和13处完全阻塞进行了BPA治疗。BPA治疗带来了临床和血流动力学改善。WHO心功能分级从BPA治疗前改善至治疗后(p = 0.018),6分钟步行距离(6 MWD)从304米增加至384米(p = 0.03),N末端脑钠肽前体(NT - proBNP)从1248 pg/ml降至730 pg/ml(p < 0.001)。平均肺动脉压(PAP)和肺血管阻力(PVR)下降(p = 0.01),而心输出量(CO)和心脏指数(CI)增加(p = 0.01)。在血管造影复查时,所有扩张的动脉均保持通畅。未发生重大并发症,所有接受治疗的患者均存活。仅2例患者发生了轻微的短暂性再灌注肺水肿,经补充氧气后反应良好。
使用压力导丝评估肺内生理学并通过IVUS和OCT精确评估解剖结构的改良BPA可改善血流动力学和功能,在无法手术的远端CTEPH中并发症最少。这一观察结果需要在大型前瞻性研究中进一步验证。